AAAAAA

   
Results: 1-10 |
Results: 10
10-year biochemical (prostate-specific antigen) control of prostate cancerwith I-125 brachytherapy
Authors: Grimm, PD Blasko, JC Sylvester, JE Meier, RM Cavanagh, W
Citation: Pd. Grimm et al., 10-year biochemical (prostate-specific antigen) control of prostate cancerwith I-125 brachytherapy, INT J RAD O, 51(1), 2001, pp. 31-40
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer
Authors: Kattan, MW Potters, L Blasko, JC Beyer, DC Fearn, P Cavanagh, W Leibel, S Scardino, PT
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer, UROLOGY, 58(3), 2001, pp. 393-399
Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis
Authors: Sylvester, J Blasko, JC Grimm, PD Meier, R Cavanagh, W
Citation: J. Sylvester et al., Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis, MOL UROL, 4(3), 2000, pp. 155-159
Regarding Blasko et al. Pallidium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46 : 839-850 - Response
Authors: Blasko, JC Grimm, PD Sylvester, JE Cavanagh, W
Citation: Jc. Blasko et al., Regarding Blasko et al. Pallidium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46 : 839-850 - Response, INT J RAD O, 48(4), 2000, pp. 1267-1267
Palladium-103 brachytherapy for prostate carcinoma
Authors: Blasko, JC Grimm, PD Sylvester, JE Badiozamani, KR Hoak, D Cavanagh, W
Citation: Jc. Blasko et al., Palladium-103 brachytherapy for prostate carcinoma, INT J RAD O, 46(4), 2000, pp. 839-850
The role of external beam radiotherapy with I-125/Pd-103 brachytherapy forprostate carcinoma
Authors: Blasko, JC Grimm, PD Sylsvester, JE Cavanagh, W
Citation: Jc. Blasko et al., The role of external beam radiotherapy with I-125/Pd-103 brachytherapy forprostate carcinoma, RADIOTH ONC, 57(3), 2000, pp. 273-278
Brachytherapy
Authors: Blasko, JC
Citation: Jc. Blasko, Brachytherapy, UROLOGY, 55(3), 2000, pp. 306-308
Neoadjuvant androgen ablation combined with external-beam radiation therapy and permanent interstitial brachytherapy boost in localized prostate cancer
Authors: Sylvester, J Blasko, JC Grimm, PD Meier, R Goy, B Colburn, G Cavanagh, W
Citation: J. Sylvester et al., Neoadjuvant androgen ablation combined with external-beam radiation therapy and permanent interstitial brachytherapy boost in localized prostate cancer, MOL UROL, 3(3), 1999, pp. 231-236
Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64
Authors: Yu, Y Anderson, LL Li, ZF Mellenberg, DE Nath, R Schell, MC Waterman, FM Wu, A Blasko, JC
Citation: Y. Yu et al., Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64, MED PHYS, 26(10), 1999, pp. 2054-2076
Reduction of radioactive seed embolization to the lung following prostate brachytherapy
Authors: Tapen, EM Blasko, JC Grimm, PD Ragde, H Luse, R Clifford, S Sylvester, J Griffin, TW
Citation: Em. Tapen et al., Reduction of radioactive seed embolization to the lung following prostate brachytherapy, INT J RAD O, 42(5), 1998, pp. 1063-1067
Risultati: 1-10 |